Neurology

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of CatumaxomabLINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024…

5 months ago
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of CirrhosisBausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

Next generation product may increase gastrointestinal luminal concentration while limiting system exposure LAVAL, QC / ACCESSWIRE / November 18, 2024…

5 months ago
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada’s Drug Agency and Quebec’s INESSSPrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada’s Drug Agency and Quebec’s INESSS

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada’s Drug Agency and Quebec’s INESSS

LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE/TSX:BHC),…

5 months ago
Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChemSea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem

Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,…

5 months ago
FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatmentFDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's…

5 months ago
Inc. Names Arbor Scientia Group as a 2024 Power Partner Award WinnerInc. Names Arbor Scientia Group as a 2024 Power Partner Award Winner

Inc. Names Arbor Scientia Group as a 2024 Power Partner Award Winner

Award won after analysis of pharmaceutical clients' feedback received by Inc. regarding Arbor Scientia Group's valuable strategic partnerships and tactical support …

5 months ago
C-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) InitiativeC-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) Initiative

C-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) Initiative

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov.…

5 months ago
Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™

Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 12, 2024 /PRNewswire/ -- The global artificial intelligence (AI) in drug discovery market is projected to…

5 months ago
Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearancePhilips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance

Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance

Philips Spectral CT 7500 RT Spectral CT 7500 RT clinical November 12, 2024 Designed specifically for use in radiation oncology,…

5 months ago
MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural ImplantsMintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants

MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants

 Latest capital raise will accelerate delivery of silicon roadmap to drive next-generation implantable devices for neurological applications LONDON, Nov. 12,…

5 months ago
Show more Posts
Show previous Posts